Sort
51,593 grants matching “hepatitis”
Molecular pathogenesis of blastomycosis
$648,248Bruce Steven Klein · University Of Wisconsin-Madison · R37 · FY2022 · AI
Continuity of Care for Drug-Addicted Offenders in RI
$648,201Peter D. Friedmann · Rhode Island Hospital · U01 · FY2006 · DA
Telomerase in Development, Senescence and Neoplasia
$648,194Ronald Anthony Depinho · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Implementation science research on PrEP delivery and costing within MAT and NSP services for PWUD in Uganda
$648,190Renee A. Heffron · University Of Washington · R01 · FY2020 · DA
Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections
$648,178Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2021 · AI
Defining the targets of broad intervention antimalarial agents
$648,140Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2013 · AI
Methods for Pathway Modeling with Application to Folate
$648,081Duncan C. Thomas · University Of Southern California · R01 · FY2010 · ES
microRNAs in Human Cancer
$648,078Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2009 · CA
Defining the therapeutic efficacy, tolerogenic potential, and genotoxicity of liver-targeted AAV gene therapy for hemophilia A
$648,076Graca Duarte Almeida-Porada · Wake Forest University Health Sciences · R01 · FY2024 · HL
Research Project 1 - Hepatocellular Genetic Epidemiology of Fatty Liver Disease in Hispanics
$648,026Joanne E Curran · University Of Texas Rio Grande Valley · U54 · FY2025 · HG
Integrated University of Puerto Rico Clinical Trials Unit
$648,000Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2020 · AI
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
$647,956Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · DK
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer
$647,886Lopa Mishra · George Washington University · U01 · FY2019 · CA
Predictors of Youth-Onset Type 2 Diabetes: UAB Clinical Center
$647,882Barbara A. Gower · University Of Alabama At Birmingham · U01 · FY2025 · DK
Structural Basis of APOBEC Functions and HIV Restriction
$647,853Xiaojiang S Chen · University Of Southern California · R01 · FY2025 · AI
HEPATITIS C IN NEW IDUS: IMPLICATIONS FOR HIV PREVENTION
$647,811New York Academy Of Medicine · R01 · FY2000 · DA
Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults with Prediabetes
$647,781Courtney Marie Peterson · University Of Alabama At Birmingham · R01 · FY2023 · DK
Contextual risk factors for hepatitis C among young persons who inject drugs
$647,748Basmattee Boodram · University Of Illinois At Chicago · R01 · FY2018 · DA
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
$647,720Helen Horton · Seattle Biomedical Research Institute · R01 · FY2010 · AI
Impact on opioid use of bundling medication-assisted treatment with mHealth
$647,613David H Gustafson · University Of Wisconsin-Madison · R01 · FY2019 · DA
Mycobacterium tuberculosis antigen diversity
$647,571Joel D. Ernst · New York University School Of Medicine · R01 · FY2012 · AI
Epidemiology of HIV and Hepatitis C Among Injecting Drug Users in Tijuana
$647,542Steffanie A Strathdee · University Of California, San Diego · R01 · FY2007 · DA
Risk Stratification for and Early Detection of Liver Cancer
$647,515Fasiha Kanwal · Baylor College Of Medicine · U01 · FY2022 · CA
Alcohol Research Consortium in HIV: Implementation Research Arm
$647,365Geetanjali Chander · Johns Hopkins University · P01 · FY2023 · AA
Blood TG clearance and vascular biology
$647,320Ira Jay Goldberg · New York University D/B/A Nyu Long Island School Of Medicine · P01 · FY2024 · HL